RESEARCH COORDINATING COUNCIL
This workgroup will be comprised of 12-15 members and will include researchers, community pharmacists, and personnel from drug plans and potential data aggregators. The group will develop plans for demonstration projects that can be initiated in 2008, and will also serve as a coordinating/oversight body for the demonstration projects.
Co-Chairs:
Eleanor M. Perfetto, PhD, MS, Senior Director, Evidence Based Strategies
Pfizer, Inc
Eugene Reeder, RPh, PhD
Xcenda
|